权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Role of HCV exosomes in intercellular communication

HCV 外泌体在细胞间通讯中的作用

基本信息

批准号：
10549367
负责人：
Young S. Hahn
金额：
$ 42.41万
依托单位：
UNIVERSITY OF VIRGINIA
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-04-15 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10549367
关键词：
Affect Anti-Inflammatory Agents Antiviral Agents Apoptotic Automobile Driving Binding Biological Markers Bypass CASP3 gene Cell Differentiation process Cells Chronic Chronic Hepatitis C Cirrhosis Clinical Coculture Techniques Data Development Disease Progression Endothelial Cells Equilibrium Fibrosis Frequencies Generations Goals Health Hepatic Hepatic Stellate Cell Hepatitis C Hepatitis C Therapy Hepatitis C virus Hepatocyte Homeostasis Human Immune Immunotherapeutic agent In Vitro Inflammatory Inflammatory Response Life Liver Liver Fibrosis Liver diseases Macrophage Maintenance Mediating Membrane MicroRNAs Molecular Outcome Pathogenesis Pathogenicity Pathologic Pathway interactions Patients Persons Plasminogen Inactivators Play Population Pre-Clinical Model Prevention Primary carcinoma of the liver cells Principal Investigator Process Production Profibrotic signal Regulation Reporting Research Risk Role Severities Signal Transduction Signaling Molecule Surface Testing Therapeutic Therapeutic Agents Transforming Growth Factor beta Virus Work chronic liver disease cytokine design end stage liver disease exosome extracellular vesicles humanized mouse immunoregulation in vivo insight intercellular communication liver development liver inflammation monocyte mouse model nanoparticle delivery new therapeutic target novel novel therapeutic intervention peripheral blood prevent programs stellate cell transmission process

项目摘要

Program Director/Principal Investigator (Hahn, Young S.): Project Summary: Chronic HCV infection affects an estimated 3% of the world's population (>180 million people) and is a worldwide health problem causing end-stage liver diseases including hepatocellular carcinoma (HCC). The development of HCV-related HCC occurs by advanced fibrosis or cirrhosis. The clinical outcome of HCV infection and HCC risk depends on a balance between pro- and anti-inflammatory cytokines and the severity of liver inflammation. Our preliminary data show that exosomes released from HCV-infected hepatocytes contain the immunoregulatory molecules such as TGF-β. Importantly, HCV exosmes derived from infected hepatocytes promote intercellular communication with non-parenchymal cells such as Mφ and LSEC. As a result of receiving signaling from HCV exosomes, Mφ and LSEC are differentiated into fibrotic cells, that activate stellate cells and induce the development of liver fibrosis. The overall goal of this project is to define the mechanism by which HCV-derived exosomes from infected hepatocytes drive pro-fibrotic liver microenvironment and explore potential therapeutic agents to prevent liver fibrosis. In Aim 1, we propose to identify key molecular machinery required for the secretion of hepatocyte exosomes after HCV infection in in vitro and in vivo. In Aim 2, we will determine how HCV-derived exosomes induce the activation of fibrotic M2-like Mφ. In Aim 3, we will determine how HCV-derived exosomes induce fibrotic LSEC differentiation and explore a therapeutic strategy for preventing fibrosis. The studies proposed here will break new ground for identifying factors crucial for driving pro-fibrotic liver microenvironment and will help to develop novel therapeutic targets for the prevention of liver fibrosis. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page

项目主任/首席调查员(Hahn，Young S.)：项目总结：据估计，慢性丙型肝炎病毒感染影响着世界3%的人口(1.8亿人)，是一种导致终末期肝病的世界性健康问题，包括肝细胞癌(HCC)。这个丙型肝炎病毒相关性肝细胞癌的发生是由晚期纤维化或肝硬变引起的。丙型肝炎的临床转归感染和肝癌的风险取决于促炎和抗炎细胞因子之间的平衡以及肝脏发炎。我们的初步数据显示，从感染丙型肝炎病毒的肝细胞释放的外切体含有转化生长因子-β等免疫调节分子。重要的是，丙型肝炎病毒外切酶来源于感染的肝细胞。促进与非实质细胞如M、φ和LSec的细胞间通讯。由于…… 在接受丙型肝炎病毒外体的信号后，Mφ和LSec被分化为纤维化细胞，激活星状细胞细胞，并诱导肝纤维化的发展。该项目的总体目标是通过以下方式定义该机制感染肝细胞中哪些丙型肝炎病毒外切体驱动肝纤维化微环境及探讨预防肝纤维化的潜在治疗药物。在目标1中，我们建议识别关键的分子机制在体外和体内，丙型肝炎病毒感染后肝细胞外切体的分泌所需。在目标2中，我们将确定丙型肝炎病毒来源的外切体如何诱导纤维化的M2样Mφ的激活。在目标3中，我们将确定丙型肝炎病毒来源的外切体如何诱导纤维性LSEC分化及探索治疗策略预防纤维化。这里提出的研究将为确定驾驶的关键因素开辟新的天地有利于肝纤维化的微环境，将有助于开发预防肝脏的新的治疗靶点纤维化症。 PHS 398/2590(06/09版)页面续格式页面